Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

المؤلفون: Giannini, Edoardo G.¹ (AUTHOR) ; Aglitti, Andrea² (AUTHOR); Borzio, Mauro³ (AUTHOR); Gambato, Martina⁴ (AUTHOR); Guarino, Maria⁵ (AUTHOR); Iavarone, Massimo⁶ (AUTHOR); Lai, Quirino⁷ (AUTHOR); Levi Sandri, Giovanni Battista⁸ (AUTHOR); Melandro, Fabio⁹ (AUTHOR); Morisco, Filomena⁵ (AUTHOR); Ponziani, Francesca Romana¹⁰ (AUTHOR); Rendina, Maria¹¹ (AUTHOR); Russo, Francesco Paolo¹² (AUTHOR); Sacco, Rodolfo¹³ (AUTHOR); Viganò, Mauro¹⁴ (AUTHOR); Vitale, Alessandro¹⁵ (AUTHOR); Trevisani, Franco¹⁶ (AUTHOR)
المصدر:
Cancers. Nov2019, Vol. 11 Issue 11, p1689-1689. 1p.